Our Pricing

Can I Take Mounjaro With Gallstones? UK Clinical Guidance

Published: 10 September 2026

Can I take Mounjaro with gallstones is a critical safety question many patients ask before starting tirzepatide treatment in the UK. While Mounjaro is not absolutely contraindicated in patients with existing gallstones, rapid weight loss from GLP-1 receptor agonists can increase the risk of gallbladder complications, including cholecystitis and cholelithiasis progression. UK prescribers assess each patient individually, considering gallstone symptoms, gallbladder function, and overall medical history before approval.

Can I Take Mounjaro With Gallstones? Understanding the Clinical Risk

The question of whether you can take Mounjaro with gallstones depends on several clinical factors, including whether your gallstones are symptomatic, the rate of weight loss expected, and your overall gallbladder health. Mounjaro (tirzepatide) itself does not directly cause gallstones, but rapid weight loss—a common effect of GLP-1/GIP receptor agonists—can precipitate gallbladder complications in patients with pre-existing cholelithiasis [1]. In the SURPASS clinical trial programme, gallbladder-related adverse events occurred in approximately 1.5–2.6% of tirzepatide-treated patients, compared to 0.7% in placebo groups [2].

UK prescribers typically evaluate gallstone patients on a case-by-case basis. Asymptomatic gallstones (silent stones detected incidentally on imaging) may not preclude Mounjaro use, provided the patient is monitored closely for symptoms such as right upper quadrant pain, nausea, or jaundice. However, if you have a history of symptomatic gallstones, biliary colic, or acute cholecystitis, your prescriber may recommend surgical consultation or cholecystectomy before initiating tirzepatide therapy [3]. This individualised approach ensures patient safety while maximising the metabolic benefits of Mounjaro.

Why Does Mounjaro Increase Gallstone Risk in Some Patients?

Understanding why you might be concerned about whether you can take Mounjaro with gallstones requires knowledge of gallbladder physiology during weight loss. Rapid weight reduction—especially losses exceeding 1.5 kg per week—alters bile composition, increasing cholesterol saturation and reducing gallbladder motility [4]. This creates an environment conducive to gallstone formation or enlargement of existing stones, potentially leading to biliary obstruction or inflammation.

Mounjaro promotes significant weight loss through dual GLP-1 and GIP receptor agonism, with clinical trial participants losing an average of 15–22% of body weight over 72 weeks [1]. While this metabolic benefit is substantial, the speed of weight reduction can transiently increase gallstone risk in the first 6–12 months of treatment. UK clinical guidelines recommend monitoring for gallbladder symptoms during the initial titration phase, particularly in patients with known cholelithiasis or risk factors such as obesity, female sex, rapid weight loss history, or metabolic syndrome [3].

Gallbladder Motility and GLP-1 Receptor Agonists

GLP-1 receptor agonists like tirzepatide slow gastric emptying and may reduce gallbladder contractility, contributing to bile stasis. This pharmacological effect, combined with rapid weight loss, explains the modest increase in gallbladder-related adverse events observed in large-scale trials [2]. However, the absolute risk remains low, and most patients tolerate Mounjaro without gallbladder complications, even in the presence of asymptomatic gallstones.

Can I Take Mounjaro With Gallstones if They Are Asymptomatic?

If your gallstones are asymptomatic—meaning they were discovered incidentally on ultrasound or CT scan and have never caused pain or complications—UK prescribers may approve Mounjaro treatment with appropriate monitoring. Asymptomatic gallstones are present in approximately 10–15% of the UK adult population, and the majority remain silent throughout life [4]. The decision to prescribe tirzepatide in this context balances the metabolic benefits of weight loss against the potential for gallstone-related symptoms to emerge during treatment.

During your online clinical assessment at Cured Pharmacy, you will be asked about any history of gallbladder disease, including asymptomatic stones. Our UK-registered prescribers review imaging reports, symptom history, and risk factors before making a prescribing decision. If Mounjaro is deemed appropriate, you will receive clear guidance on recognising gallbladder symptoms—such as sudden right upper quadrant pain, fever, or jaundice—and instructions to seek urgent medical attention if these occur. This proactive monitoring approach allows many patients with asymptomatic gallstones to safely benefit from Mounjaro therapy [3].

Monitoring Recommendations for Gallstone Patients on Mounjaro

UK clinical best practice for patients with asymptomatic gallstones starting Mounjaro includes baseline liver function tests, patient education on warning symptoms, and regular follow-up during the first six months of treatment. Some prescribers may recommend a repeat ultrasound at 6–12 months to assess gallstone progression, particularly in patients with multiple or large stones [4]. This vigilant approach minimises risk while enabling effective weight management.

When Should I Not Take Mounjaro With Gallstones?

There are specific clinical scenarios where the answer to can I take Mounjaro with gallstones is a clear no, at least until gallbladder issues are resolved. If you have symptomatic gallstones—characterised by recurrent biliary colic, right upper quadrant pain after meals, nausea, vomiting, or jaundice—Mounjaro is generally not recommended until you have undergone cholecystectomy (gallbladder removal) or definitive treatment [3]. Active cholecystitis, choledocholithiasis (stones in the bile duct), or pancreatitis related to gallstones are contraindications to starting any weight loss medication that accelerates bile metabolism.

Additionally, if you have a history of gallbladder surgery complications, biliary strictures, or chronic cholecystitis, your prescriber will carefully evaluate whether Mounjaro is appropriate. In some cases, alternative weight loss treatments with lower gallbladder risk—such as orlistat or lifestyle modification programmes—may be recommended first. The priority is always patient safety, and UK prescribers adhere to MHRA and NICE guidance when assessing suitability for tirzepatide therapy in patients with gallbladder disease [2].

What Are the Symptoms of Gallbladder Problems on Mounjaro?

Patients asking can I take Mounjaro with gallstones must be educated on recognising gallbladder complications early. The most common symptom is biliary colic—a sudden, severe pain in the right upper quadrant or epigastrium, often radiating to the right shoulder or back, typically occurring 30–90 minutes after a fatty meal [4]. This pain may last several hours and is caused by a gallstone temporarily obstructing the cystic duct. Other warning signs include persistent nausea, vomiting, fever, chills, dark urine, pale stools, and jaundice (yellowing of the skin or eyes), which may indicate cholecystitis or choledocholithiasis [3].

If you experience any of these symptoms while taking Mounjaro, stop the medication immediately and seek urgent medical attention. Early recognition and treatment of gallbladder complications can prevent serious outcomes such as gallbladder perforation, sepsis, or pancreatitis. UK patients can contact NHS 111 for guidance or attend an emergency department if symptoms are severe. At Cured Pharmacy, our clinical team provides clear safety information during the prescribing process, ensuring you know what to watch for and when to seek help [2].

Emergency Red Flags for Gallbladder Disease

Seek immediate emergency care (999 or A&E) if you develop severe, unrelenting abdominal pain, high fever above 38.5°C, jaundice, confusion, or signs of sepsis while on Mounjaro. These symptoms may indicate acute cholecystitis, ascending cholangitis, or gallstone pancreatitis—all medical emergencies requiring urgent intervention [4]. Do not delay seeking help if you suspect a serious gallbladder complication.

How Cured Pharmacy Assesses Gallstone Risk Before Prescribing Mounjaro

When you complete your online clinical assessment at Cured Pharmacy to determine if you can take Mounjaro with gallstones, our UK-registered prescribers conduct a thorough review of your medical history, including any gallbladder imaging, previous biliary symptoms, surgical history, and current medications. This assessment is completed by GPhC-registered clinicians under the supervision of our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensuring compliance with MHRA and GPhC standards [3]. Mounjaro is available from £124.99 at Cured Pharmacy, with transparent pricing displayed before your consultation and £20 off your first order using code Weightlossnew.

If your assessment reveals asymptomatic gallstones with no history of complications, our prescribers may approve Mounjaro with enhanced monitoring and patient education. If you have symptomatic gallstones or active gallbladder disease, the prescriber will recommend appropriate specialist referral or alternative treatment options. This individualised, evidence-based approach ensures that every patient receives safe, effective care tailored to their unique clinical circumstances. All consultations are conducted online in under three minutes, with free next-day delivery across the UK and 100% discreet packaging [2].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. [accessed 10 September 2026]
2. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): A double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. [accessed 10 September 2026]
3. National Institute for Health and Care Excellence. (2023). Obesity: Identification, assessment and management (CG189). NICE. [accessed 10 September 2026]
4. Stokes, C. S., Gluud, L. L., Casper, M., & Lammert, F. (2014). Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: A meta-analysis of randomized controlled trials. Clinical Gastroenterology and Hepatology, 12(7), 1090–1100. [accessed 10 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.